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ment of Anatomy, Birmingham University
Medical School.
We have previously reported (Whur et al.,
Br. J. Cancer, 1973, 28, 417) that intraperi-
toneal injections of soybean trypsin inhibitor
into tumour bearing mice reduced the number
of tumour cells recoverable in the ascitic
fluid by up to 92%, and tentatively proposed
on the basis of scanning E.M. observations
that this reduction was attributable to large
numbers of tumour cells adhering to the
peritoneum. We have traced the fate of
radiolabelled Ehrlich ascites tumour cells in
autoradiographs ofsections ofthe peritoneum
and of cells from the ascitic fluid from trypsin
inhibitor treated and untreated mice.
Our results indicate that cells on the
peritoneum of treated mice, previously
postulated to be tumour cells, are in fact of
host origin. The disappearance of tumour
cells from ascitic fluid of trypsin inhibitor
treated mice is probably attributable to an
enhanced inflammatory response in these
animals.
GROWTH OF A CANINE SOLID MAM-
MARY CARCINOMA IN VITRO AND
IN Nu MICE. L. N. OWEN and D. R.
MORGAN, Department of Clinical Veterinary
Medicine, University of Cambridge.
The biological behaviour of spontaneous
anaplastic or solid carcinoma ofthe mammary
gland in the dog is similar to carcinoma ofthe
breast in women.
A 14-year old cross-bred terrier bitch
developed rapidly growing and infiltrating
solid carcinomata in the pelvic mammary
glands on both sides. Following euthenasia,
metastatic tumours in the lungs were made
into a cell suspension and cultured in TC 199
containing 20% FCS. Better growth
occurred following transfer to RPMI medium
+ 30% FCS or a very complex medium
containing glutathione, cortisol and insulin.
The culture has now reached its 40th passage
with an approximate doubling time of5 days.
Cells from the 30th passage were injected
subcutaneously into a Nude mouse and within
22 days palpable tumours appeared. The
histological diagnosis was solid carcinoma of
similar appearance to the original primary
and metastatic tumours in the dog. Tumour
cells grown in tissue culture have been
injected into foetal dogs and newborn
puppies immunosuppressed with antilympho-
cyte serum.
GROWTH CHARACTERISTICS OF A
HUMAN BLADDER TUMOUR SUB-
CUTANEOUSLY IMPLANTED IN
IMMUNE DEFICIENT MICE. C. R.
FRANKS, Imperial Cancer Research Fund
Breast Unit, Guy's Hospital, London, D. R.
TURNER, Department of Pathology, Guy's
Hospital Medical School, London, and D.
BISHoP andF. T. PERKINS, National Institute
ofBiological Standards and Control, London.
In previous studies (Franks et al.,
Nature, Lond., 1973, 243, 91 andProc. R. Soc.
Med. (in press) 1974) it has been shown that
human tumours can be grown by sub-
cutaneous implantation in immune deficient
mice. Growth has been assessed by serial
measurements of the vertical and transverse
diameters of the palpable tumour, and
viability confirmed retrospectively at
autopsy.
In this study, a papillary cell carcinoma of
the human bladder on its second passage, 117
days after removal from the patient, was
subcutaneously implanted in 5 mice. During
the 70-day experimental period, needle
biopsy was performed under anaesthesia at
14-day intervals using a disposable Menghini
biopsy needle. The transverse and vertical
diameters of the tumours were also measured
using Vernier calipers.
The results show that between Day + 20
and Day + 25 there is a critical period
during which the implanted tumours appear
to undergo a process of selection, following
which there is either an active increase in
size or regression.
AGGREGATION KINETICS OF NOR-
MAL AND TRANSFORMED BHK 21
FIBROBLASTS USING A PARTICLE
COUNTER COUPLED WITH A CHAN-
NEL ANALYSER. P. WHUR and H.
KOPPEL, Cell Biology Unit, Marie Curie
Memorial Foundation, Oxted.
We have examined cell aggregation in
shaking suspensions using a Coulter model Fn
counter coupled with a P64 channel analyser.
After calibration this apparatus is used to
detect the number of cells present in aggre-
gates up to a maximum size ofabout 50 cells,
and thus to calculate the net redistribution of
cells between aggregates as aggregation
progresses.